Country: United States
Language: English
Source: NLM (National Library of Medicine)
RETINOL (UNII: G2SH0XKK91) (RETINOL - UNII:G2SH0XKK91)
Hospira Worldwide, Inc.
RETINOL
RETINOL 1 mg in 5 mL
PRESCRIPTION DRUG
New Drug Application
M.V.I.-12- RETINOL, ERGOCALCIFEROL, .ALPHA.-TOCOPHEROL ACETATE, DL-, ASCORBIC ACID, NIACINAMIDE, RIBOFLAVIN 5-PHOSPHATE SODIUM, THIAMINE HYDROCHLORIDE, PYRIDOXINE HYDROCHLORIDE, DEXPANTHENOL, BIOTIN, FOLIC ACID, AND CYANOCOBALAMIN HOSPIRA WORLDWIDE, INC. ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE M.V.I.-12™ PHARMACY BULK PACKAGE (MULTI- VITAMIN INFUSION WITHOUT VITAMIN K) SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR M.V.I.-12™ PHARMACY BULK PACKAGE (MULTI-VITAMIN INFUSION WITHOUT VITAMIN K). M.V.I.-12™ PHARMACY BULK PACKAGE (MULTI-VITAMIN INFUSION WITHOUT VITAMIN K) DILUTION FOR INTRAVENOUS INFUSION ONLY. INITIAL U.S. APPROVAL: 1953 RECENT MAJOR CHANGES Dosage and Administration (2.1) (2.3) (2.4) 06/2012 Warnings and Precautions (5.1) (5.2) (5.3) (5.4) (5.5) (5.6) (5.7) (5.8) 06/2012 INDICATIONS AND USAGE M.V.I.-12™ Pharmacy Bulk Package is indicated for prevention of vitamin deficiency in adults and children aged 11 years and above who are on warfarin anticoagulant therapy receiving home parenteral nutrition. (1) DOSAGE AND ADMINISTRATION • • DOSAGE FORMS AND STRENGTHS M.V.I.-12™ Pharmacy Bulk Package is a sterile product consisting of two vials labeled Vial 1 (50 mL) and Vial 2 (50 mL). The mixed solution (100 mL) will provide ten 10 mL single doses. (3) CONTRAINDICATIONS Hypersensitivity to any of the vitamins in this product or an existing hypervitaminosis. (4) WARNINGS AND PRECAUTIONS • • • • • • • • ADVERSE REACTIONS There have been rare reports of the following types of reactions: • • • • TO REPORT SUSPECTED ADVERSE REACTIONS, CONTACT HOSPIRA, INC. AT 1-800-441-4100 OR ELECTRONICALLY AT PRODUCTCOMPLAINTSPP@HOSPIRA.COM, OR FDA AT 1-800-FDA-1088 OR _WWW.FDA.GOV/MEDWATCH_. DRUG INTERACTIONS M.V.I.-12™ is ready for immediate use in adults and children aged 11 years and above when added to intravenous infusion fluids. (2) M.V.I.-12™ SHOULD BE ASEPTICALLY TRANSFERRED TO THE INFUSION F Read the complete document